Tesamorelin The care checkbook
Chapter index

Care guide / Check risks and follow-up

Know the risks and the urgent signs.

Ask how the health professional assessing you will check your history and follow the treatment. A general claim that a medicine is “safe” skips that work.

Read this chapter ↓

Keep this question

Who handles a new symptom?

Discuss your history and possible effects

The September 2026 tesamorelin (Egrifta SV, Egrifta WR) labels rule out use during pregnancy or with active cancer.

Growth hormone is a chemical that carries messages in the body; tesamorelin makes the body release more of it.

The labels also rule out ingredient allergies and certain problems with the pituitary, the part of the body that releases growth hormone.

The label also calls for careful review of a past, treated cancer before starting.

Tell the person assessing you about these parts of your history.

Effects to discuss before agreeing

Tesamorelin can cause swelling from retained fluid, joint pain and tingling linked to a squeezed wrist nerve.

The label reports reactions at the injection spot, muscle aches and allergic-type reactions.

It can also raise blood sugar; the label calls for checks before treatment and during it.

The blood contains IGF-1, which helps the body’s cells grow; tesamorelin raises its level.

The label says the effects of keeping IGF-1 high for a long time are unknown.

The September 2026 label does not establish how tesamorelin affects blood vessels or the heart over the long term.

Ask how tesamorelin could affect the other medicines you take.

Severe allergic signs need urgent care

Breathing trouble, difficulty with swallowing, or a face or tongue that swells may point to a severe allergic reaction.

For severe symptoms, MedlinePlus directs people to emergency services or the nearest emergency room because this reaction can threaten life.

These are reasons for urgent help, not a way to diagnose the cause yourself.

Get the response plan in writing

  • Who answers a new symptom between visits?
  • Which symptoms call for prompt contact with the person treating me?
  • Who reviews the blood tests and tells me the results?
  • How do I reach someone if the medicine instructions are unclear?

MedWatch is a free service from the US Food and Drug Administration where patients can report problems they suspect are linked to a medicine.

A report records a suspected problem; it cannot, by itself, show the medicine caused that problem.

Source notes for this chapter